NO174509B - Analogifremgangsmaate for fremstilling av terapeutisk aktive (1H-azol- 1-ylmetyl)substituerte kinolin-, kinazolin- eller kinoksazolinderivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive (1H-azol- 1-ylmetyl)substituerte kinolin-, kinazolin- eller kinoksazolinderivater Download PDF

Info

Publication number
NO174509B
NO174509B NO894734A NO894734A NO174509B NO 174509 B NO174509 B NO 174509B NO 894734 A NO894734 A NO 894734A NO 894734 A NO894734 A NO 894734A NO 174509 B NO174509 B NO 174509B
Authority
NO
Norway
Prior art keywords
formula
parts
alkyl
residue
compounds
Prior art date
Application number
NO894734A
Other languages
English (en)
Norwegian (no)
Other versions
NO174509C (fr
NO894734D0 (no
NO894734L (no
Inventor
Eddy Jean Edgard Freyne
Marc Gaston Venet
Alfons Herman Margaretha
Gerard Charles Sanz
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888827822A external-priority patent/GB8827822D0/en
Priority claimed from GB888827821A external-priority patent/GB8827821D0/en
Priority claimed from GB888827820A external-priority patent/GB8827820D0/en
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO894734D0 publication Critical patent/NO894734D0/no
Publication of NO894734L publication Critical patent/NO894734L/no
Publication of NO174509B publication Critical patent/NO174509B/no
Publication of NO174509C publication Critical patent/NO174509C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26Androgens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO894734A 1988-11-29 1989-11-28 Analogifremgangsmaate for fremstilling av terapeutisk aktive (1H-azol- 1-ylmetyl)substituerte kinolin-, kinazolin- eller kinoksazolinderivater NO174509B (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB888827822A GB8827822D0 (en) 1988-11-29 1988-11-29 (1h-azol-1-ylmethyl)substituted quinoline derivatives
GB888827821A GB8827821D0 (en) 1988-11-29 1988-11-29 (1h-azol-1-ylmethyl)substituted quinoline derivatives
GB888827820A GB8827820D0 (en) 1988-11-29 1988-11-29 (1h-azol-1-ylmethyl)substituted quinoline derivatives

Publications (4)

Publication Number Publication Date
NO894734D0 NO894734D0 (no) 1989-11-28
NO894734L NO894734L (no) 1990-05-30
NO174509B true NO174509B (no) 1994-02-07
NO174509C NO174509C (fr) 1994-05-18

Family

ID=27264207

Family Applications (1)

Application Number Title Priority Date Filing Date
NO894734A NO174509B (no) 1988-11-29 1989-11-28 Analogifremgangsmaate for fremstilling av terapeutisk aktive (1H-azol- 1-ylmetyl)substituerte kinolin-, kinazolin- eller kinoksazolinderivater

Country Status (22)

Country Link
EP (1) EP0371564B1 (fr)
JP (1) JP2916181B2 (fr)
CN (3) CN1033752C (fr)
AT (1) ATE124941T1 (fr)
AU (1) AU620946B2 (fr)
CA (1) CA2002864C (fr)
CY (1) CY1920A (fr)
DE (1) DE68923430T2 (fr)
DK (1) DK172748B1 (fr)
ES (1) ES2088889T3 (fr)
FI (1) FI101964B1 (fr)
GR (1) GR3017351T3 (fr)
HK (1) HK118196A (fr)
HU (2) HU205106B (fr)
IE (1) IE67803B1 (fr)
IL (1) IL92486A (fr)
MY (1) MY105871A (fr)
NO (1) NO174509B (fr)
NZ (1) NZ231441A (fr)
PT (1) PT92448B (fr)
RU (1) RU1780536C (fr)
ZW (1) ZW15889A1 (fr)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0556393B1 (fr) * 1990-11-06 2000-07-26 Yamanouchi Pharmaceutical Co. Ltd. Derive de pyrazine fusionnee
DE4107038A1 (de) * 1991-03-01 1992-09-03 Schering Ag Triheteroarylmethane, verfahren zu deren herstellung, pharmazeutische praeparate die diese enthalten sowie ihre verwendung zur herstellung von arzneimitteln
KR100239003B1 (ko) * 1992-10-27 2000-02-01 디르크 반테 항헬리코박터 활성을 갖는 4-퀴놀리닐 유도체
NO940245D0 (no) * 1993-01-28 1994-01-24 Takeda Chemical Industries Ltd Quinolin eller quinazolinderivater, deres fremstilling og anvendelse
ATE196145T1 (de) * 1993-06-17 2000-09-15 Otsuka Pharma Co Ltd Phosphonsäurediesterderivate
TW316902B (fr) * 1994-12-28 1997-10-01 Janssen Pharmaceutica Nv
US6110911A (en) * 1995-06-07 2000-08-29 Warner-Lambert Company Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
MY132385A (en) * 1995-08-31 2007-10-31 Novartis Ag 2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives
TW349948B (en) * 1995-10-31 1999-01-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 2-quinolone derivatives
CZ293296B6 (cs) * 1995-12-08 2004-03-17 Janssen Pharmaceutica N.V. (Imidazol-5-yl)methyl-2-chinolinonové deriváty inhibující farnesyl protein transferázu
US5739338A (en) * 1996-11-05 1998-04-14 Allergan N-aryl substituted tetrahydroquinolines having retinoid agonist, retinoid antagonist or retinoid inverse agonist type biological activity
TW591030B (en) 1997-03-10 2004-06-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles
ATE366250T1 (de) 1997-04-25 2007-07-15 Janssen Pharmaceutica Nv Chinazolinone die farnesyltransferase hemmen
TW403740B (en) 1997-06-10 2000-09-01 Novartis Ag Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide
JP2001525400A (ja) 1997-12-11 2001-12-11 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ レチノイン酸擬似アニリド
BR9913315A (pt) * 1998-08-27 2001-05-22 Pfizer Prod Inc Derivados de quinolin-2-ona úteis como agentes anticâncer
PL199080B1 (pl) * 1998-12-23 2008-08-29 Janssen Pharmaceutica Nv Pochodna chinoliny o pierścieniu 1,2-skondensowanym i sposób jej otrzymywania, kompozycja farmaceutyczna i sposób jej otrzymywania, pochodna chinoliny i sposób jej otrzymywania
US6914062B2 (en) 2000-06-30 2005-07-05 Banyu Pharmaceutical Co., Ltd. Pyrazinone derivatives
WO2002024682A1 (fr) 2000-09-25 2002-03-28 Janssen Pharmaceutica N.V. Derives de quinoline et de quinazoline inhibant la farnesyl transferase comme inhibiteurs de farnesyl transferase
US7196094B2 (en) 2000-09-25 2007-03-27 Janssen Pharmaceutica, N.V. Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
JP4974437B2 (ja) 2000-09-25 2012-07-11 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ファルネシルトランスフェラーゼを阻害する6−[(置換フェニル)メチル]−キノリンおよびキナゾリン誘導体
WO2002024687A1 (fr) 2000-09-25 2002-03-28 Janssen Pharmaceutica N.V. Derives de 6-heterocyclylmethyl quinolinone inhibant la farnesyl transferase
WO2002042296A1 (fr) * 2000-11-21 2002-05-30 Janssen Pharmaceutica N.V. Derives benzoheterocycliques inhibant la farnesyl transferase
WO2002051835A1 (fr) 2000-12-27 2002-07-04 Janssen Pharmaceutica N.V. Quinoline 4-substituee inhibitrice de la transferase farnesyl et derives de quinazoline
KR100417705B1 (ko) * 2001-07-24 2004-02-11 한국화학연구원 4-아졸일-2-퀴놀리논 유도체 및 이를 포함하는 살균제조성물
JP4384505B2 (ja) 2002-04-15 2009-12-16 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ファルネシルトランスフェラーゼを阻害する炭素連結イミダゾールもしくはトリアゾール置換三環状キナゾリン誘導体
FR2860235A1 (fr) * 2003-09-29 2005-04-01 Yang Ji Chemical Company Ltd Utilisation d'un compose de formule (i) inhibiteur de l'aromatase a des fins therapeutiques et composes de formule (i) en tant que tels
CN1882547B (zh) * 2003-11-20 2011-04-13 詹森药业有限公司 用作聚(adp-核糖)聚合酶抑制剂的6-烯基和6-苯基烷基取代的2-喹啉酮和2-喹喔啉酮
US7928104B2 (en) * 2003-11-20 2011-04-19 Dominique Jean-Pierre Mabire 7-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
JP4864718B2 (ja) * 2003-11-20 2012-02-01 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ポリ(adp−リボース)ポリメラーゼ阻害剤としての6−アルケニルおよび6−フェニルアルキル置換2−キノリノンおよび2−キノキサリノン
KR101118582B1 (ko) 2003-11-20 2012-02-27 얀센 파마슈티카 엔.브이. 폴리(adp-리보스)폴리머라제 저해제로서의 6-알케닐 및6-페닐알킬 치환된 2-퀴놀리논 및 2-퀴녹살리논
KR101159118B1 (ko) * 2003-12-05 2012-06-22 얀센 파마슈티카 엔.브이. 폴리(adp-리보스)폴리머라제 저해제로서의 6-치환된2-퀴놀리논 및 2-퀴녹살리논
CN1890225A (zh) * 2003-12-10 2007-01-03 詹森药业有限公司 作为多聚(adp-核糖)聚合酶抑制剂的被取代的6-环己基烷基取代的2-喹啉酮和2-喹喔啉酮
CN1980913B (zh) 2004-06-30 2011-12-14 詹森药业有限公司 作为parp抑制剂的喹唑啉二酮衍生物
BRPI0512790A (pt) 2004-06-30 2008-04-08 Janssen Pharmaceutica Nv derivados de 2-alquil quinazolinona substituìdos como inibidores de parp
EA014955B1 (ru) 2004-06-30 2011-04-29 Янссен Фармацевтика Н. В. Производные фталазина в качестве ингибиторов parp
US8426429B2 (en) 2004-08-06 2013-04-23 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
US8383637B2 (en) 2004-08-06 2013-02-26 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
US8436006B2 (en) 2004-08-06 2013-05-07 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
JP4643948B2 (ja) * 2004-08-23 2011-03-02 大日本住友製薬株式会社 キナゾリノン化合物の安定化方法
US7932261B2 (en) 2006-02-06 2011-04-26 Janssen Pharmaceutica Nv Macrocycle derivatives useful as inhibitors of β-secretase (BACE)
US7868022B2 (en) 2006-02-06 2011-01-11 Janssen Pharmaceutica Nv 2-amino-quinoline derivatives useful as inhibitors of β-secretase (BACE)
KR101307497B1 (ko) * 2006-04-19 2013-09-11 주식회사 동진쎄미켐 디이미다졸계 화합물 및 이를 이용한 유기발광소자
US7429589B2 (en) * 2006-04-27 2008-09-30 Hoffmann-La Roche Inc. Mono-nitration of aromatic compounds via nitrate salts
US20080076800A1 (en) * 2006-08-24 2008-03-27 Huang Kenneth H Benzene, Pyridine, and Pyridazine Derivatives
WO2008107478A1 (fr) 2007-03-08 2008-09-12 Janssen Pharmaceutica Nv Dérivés de quinolinone comme inhibiteurs de parp et de tank
WO2009053373A1 (fr) 2007-10-26 2009-04-30 Janssen Pharmaceutica Nv Dérivés de quinolinone en tant qu'inhibiteurs de parp
KR20100107045A (ko) 2008-01-28 2010-10-04 얀센 파마슈티카 엔.브이. β-세크레타아제(BACE)의 저해제로서 유용한 6-치환된-티오-2-아미노-퀴놀린 유도체
WO2009118382A1 (fr) 2008-03-27 2009-10-01 Janssen Pharmaceutica Nv Tétrahydrophénanthridinones et tétrahydrocyclopentaquinolinones comme inhibiteurs de la polymérisation de la tubuline et de parp
EP2260026B1 (fr) 2008-03-27 2011-06-22 Janssen Pharmaceutica, N.V. Dérivés de quinazolinone comme inhibiteurs de la polymérisation de la tubuline
GB0914767D0 (en) 2009-08-24 2009-09-30 Sterix Ltd Compound
US9394290B2 (en) * 2010-10-21 2016-07-19 Universitaet Des Saarlandes Campus Saarbruecken Selective CYP11B1 inhibitors for the treatment of cortisol dependent diseases
US9199975B2 (en) 2011-09-30 2015-12-01 Asana Biosciences, Llc Biaryl imidazole derivatives for regulating CYP17
WO2013049565A1 (fr) * 2011-09-30 2013-04-04 Endo Pharmaceuticals Inc. Dérivés imidazoles en tant qu'inhibiteurs de cyp17 pour le traitement du cancer
CA2888210C (fr) 2012-10-16 2021-02-09 Janssen Pharmaceutica Nv Modulateurs de ror-gamma-t de type quinolinyle a liaison methylene
KR20150070348A (ko) 2012-10-16 2015-06-24 얀센 파마슈티카 엔.브이. RoRγt의 헤테로아릴 결합 퀴놀리닐 조절제
EP2909193B1 (fr) 2012-10-16 2017-04-19 Janssen Pharmaceutica NV Modulateurs de ror-gamma-t de type quinolinyle à liaison phényle
KR20160068956A (ko) * 2013-10-15 2016-06-15 얀센 파마슈티카 엔.브이. RORyT의 퀴놀리닐 조절제
US9221804B2 (en) 2013-10-15 2015-12-29 Janssen Pharmaceutica Nv Secondary alcohol quinolinyl modulators of RORγt
US9403816B2 (en) 2013-10-15 2016-08-02 Janssen Pharmaceutica Nv Phenyl linked quinolinyl modulators of RORγt
JP6423423B2 (ja) 2013-10-15 2018-11-14 ヤンセン ファーマシューティカ エヌ.ベー. Rorγtのアルキル結合キノリニルモジュレーター
US9328095B2 (en) 2013-10-15 2016-05-03 Janssen Pharmaceutica Nv Heteroaryl linked quinolinyl modulators of RORgammat
US10555941B2 (en) 2013-10-15 2020-02-11 Janssen Pharmaceutica Nv Alkyl linked quinolinyl modulators of RORγt
US9284308B2 (en) 2013-10-15 2016-03-15 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of RORγt

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2101115A (en) * 1980-10-23 1983-01-12 Pfizer Ltd Thromboxane synthetase inhibitors
US4792561A (en) * 1986-05-29 1988-12-20 Syntex (U.S.A.) Inc. Carbostyril derivatives as combined thromboxane synthetase and cyclic-AMP phosphodiesterase inhibitors
NZ221729A (en) * 1986-09-15 1989-07-27 Janssen Pharmaceutica Nv Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions
FR2629456B1 (fr) * 1988-03-31 1991-07-05 Esteve Labor Dr Derives des acides 7-(1-imidazolyl),1,4-dihydro-4-oxo-6,8-difluoro-1-cyclopropyl-3-quinoleincarboxylique, leur preparation et leur application en tant que medicaments

Also Published As

Publication number Publication date
RU1780536C (ru) 1992-12-07
NO174509C (fr) 1994-05-18
PT92448A (pt) 1990-05-31
DE68923430T2 (de) 1996-02-15
GR3017351T3 (en) 1995-12-31
HUT52498A (en) 1990-07-28
FI895687A0 (fi) 1989-11-28
ATE124941T1 (de) 1995-07-15
HK118196A (en) 1996-07-12
FI101964B (fi) 1998-09-30
CN1036003C (zh) 1997-10-01
DK172748B1 (da) 1999-06-28
DK599489A (da) 1990-05-30
CN1036002C (zh) 1997-10-01
IE893782L (en) 1990-05-29
HU205106B (en) 1992-03-30
MY105871A (en) 1995-02-28
DE68923430D1 (de) 1995-08-17
DK599489D0 (da) 1989-11-28
EP0371564A3 (fr) 1991-05-29
NZ231441A (en) 1991-05-28
EP0371564B1 (fr) 1995-07-12
HU211686A9 (en) 1995-12-28
ES2088889T3 (es) 1996-10-01
JP2916181B2 (ja) 1999-07-05
EP0371564A2 (fr) 1990-06-06
NO894734D0 (no) 1989-11-28
IL92486A0 (en) 1990-08-31
FI101964B1 (fi) 1998-09-30
CN1106004A (zh) 1995-08-02
AU620946B2 (en) 1992-02-27
CN1033752C (zh) 1997-01-08
HU896220D0 (en) 1990-02-28
IE67803B1 (en) 1996-05-01
CA2002864A1 (fr) 1990-05-29
NO894734L (no) 1990-05-30
CN1042912A (zh) 1990-06-13
CN1106005A (zh) 1995-08-02
PT92448B (pt) 1995-07-18
AU4564689A (en) 1990-06-07
CY1920A (en) 1997-03-07
JPH02223579A (ja) 1990-09-05
ZW15889A1 (en) 1991-07-17
IL92486A (en) 1993-07-08
CA2002864C (fr) 1999-11-16

Similar Documents

Publication Publication Date Title
NO174509B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (1H-azol- 1-ylmetyl)substituerte kinolin-, kinazolin- eller kinoksazolinderivater
EP0293978B1 (fr) Dérivés de benzotriazole substitués par le groupe 1H-azol-1-yl-méthyle
CA2577420C (fr) Analogues de lonidamine et leur utilisation dans la contraception masculine et dans le traitement du cancer
EP2528901B9 (fr) Composés de pyrazole en tant qu'antagonistes de crth2
US20040043983A1 (en) Naphthalene derivatives as matrix metalloproteinase inhibitors
US5151421A (en) (1h-azol-1-ylmethyl) substituted quinoxaline derivatives
NO312102B1 (no) N-[4-(Heteroarylmetyl)fenyl]-Heteroarylaminer
KR20020047170A (ko) 방향족 질소 함유 6-원 고리 화합물
JPH10508317A (ja) 抗真菌活性を有する新規ピリミドン誘導体
US20040043985A1 (en) 6,6-Fused heteroaryl derivatives as matrix metalloproteinase inhibitors
US20040043986A1 (en) 5,6-Fused 3,4-dihydropyrimidine-2-one derivatives as matrix metalloproteinase inhibitors
US6869958B2 (en) Fused tetrahydropyridine derivatives as matrix metalloproteinase inhibitors
EP0641785B1 (fr) Amine tertiaire triazolylee ou un sel de celle-ci
US4943574A (en) (1H-azol-1-ylmethyl) substituted benzotriazole derivatives and pharmaceutical compositions containing them
WO2004014378A1 (fr) Derives de 3-isoquinolinone utilises comme inhibiteurs de metalloprotease de matrice
US20040266756A1 (en) Antifungal 4-substituted 5,6-dihydro-4h-pyrrolo[1,2-a][1,4] benzodiazepines
KR0149162B1 (ko) (1h-아졸-1-일메틸) 치환된 퀴놀린, 퀴나졸린 또는 퀴녹살린 유도체
JP2500849B2 (ja) トリアゾリル置換3級アミノ化合物又はその塩
US5039677A (en) 6-(1H-azol-1-ylmethyl)-1-(pyrimidinyloxy)-1H benzotriazoles